Chinese Stock Message Board

Stock discussion boards for Japanese, US and Chinese stocks

日本語English简体中文 繁體中文

HOME Monologue Trades Monthly Annual Dividends Stock Assets Total Assets Stock Lending IPO FUNDINNO Indicators Market Daily JP Stock Blog CN Stock Blog US Stock Blog JP Dividend Yields JP Curated Dividends US Curated Dividends CN Curated Dividends 日本株テンバガー候補 JP Top 50 Gainers JP Top 50 Losers JP Stock Board US Stock Board CN Stock Board J-REIT Ranking J-REIT Guide High-Div Funds Yutai Benefits Premium Yutai Club Nikkei A/D Ratio Growth A/D Ratio Investor Flows JP Disclosures US Disclosures CN Disclosures Amazonおすすめ Amazonタイムセール Kabutaro on X

688302 Hinova Pharmaceuticals Inc.海创药业Shanghai Stock Exchange

4 posts

Price chart ・ Find other stocks ・ Japanese version

Hinova Pharmaceuticals Inc. (688302) at a glance

Code
688302
Company
Hinova Pharmaceuticals Inc.
Local name
海创药业
Market
Shanghai Stock Exchange
Share price
CN¥33.59 -1.90 (-5.35%) Nov 6 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Hinova Pharmaceuticals Inc. (688302) Stock Price History

Hinova Pharmaceuticals Inc. closed at CN¥33.59 on Nov 6, 2026, +0.7% over 1 month, −29.6% over 1 year.

2026-10-09 新薬・製品の承認 自愿披露关于HP515片IIa期临床试验数据被美国肝病研究协会接受为年…2026-10-31 第3四半期報告 2026年第三季度报告2026-11-04 新薬・製品の承認 自愿披露关于HP570片临床试验申请获得美国FDA批准的公告2026-11-05 契約の締結 关于签署独家授权许可协议的公告CN¥35.49CN¥27.68Oct 8Nov 6
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥35.49Nov 5
1-Month LowCN¥27.68Oct 22
1-Week Change+10.3%vs Oct 30
1-Month Change+0.7%vs Sep 30

If you had invested CN¥10,000 1 month ago, it would be worth CN¥10,640 today (+6.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.3%, while this stock moved +6.4%.

Last 10 Trading Days

DateCloseChange% Change
Nov 6 (Fri)CN¥33.59−1.90−5.35%
Nov 5 (Thu)CN¥35.49+2.41+7.29%
Nov 4 (Wed)CN¥33.08+3.32+11.16%
Nov 3 (Tue)CN¥29.76−1.30−4.19%
Nov 2 (Mon)CN¥31.06+0.60+1.97%
Oct 30 (Fri)CN¥30.46+0.00+0.00%
Oct 29 (Thu)CN¥30.46−1.80−5.58%
Oct 28 (Wed)CN¥32.26+3.41+11.82%
Oct 27 (Tue)CN¥28.85+0.55+1.94%
Oct 26 (Mon)CN¥28.30−0.38−1.32%
2026-10-09 新薬・製品の承認 自愿披露关于HP515片IIa期临床试验数据被美国肝病研究协会接受为年…2026-10-31 第3四半期報告 2026年第三季度报告2026-11-04 新薬・製品の承認 自愿披露关于HP570片临床试验申请获得美国FDA批准的公告2026-11-05 契約の締結 关于签署独家授权许可协议的公告CN¥38.60CN¥27.68Aug 6Nov 6
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥38.60Aug 13
3-Month LowCN¥27.68Oct 22
1-Month Change+0.7%vs Sep 30
3-Month Change−2.1%vs Aug 6

If you had invested CN¥10,000 3 months ago, it would be worth CN¥9,793 today (−2.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −6.4%, while this stock moved −2.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 6 (Fri)CN¥33.59−1.90−5.35%
Nov 5 (Thu)CN¥35.49+2.41+7.29%
Nov 4 (Wed)CN¥33.08+3.32+11.16%
Nov 3 (Tue)CN¥29.76−1.30−4.19%
Nov 2 (Mon)CN¥31.06+0.60+1.97%
Oct 30 (Fri)CN¥30.46+0.00+0.00%
Oct 29 (Thu)CN¥30.46−1.80−5.58%
Oct 28 (Wed)CN¥32.26+3.41+11.82%
Oct 27 (Tue)CN¥28.85+0.55+1.94%
Oct 26 (Mon)CN¥28.30−0.38−1.32%
2026-10-09 新薬・製品の承認 自愿披露关于HP515片IIa期临床试验数据被美国肝病研究协会接受为年…2026-10-31 第3四半期報告 2026年第三季度报告2026-11-04 新薬・製品の承認 自愿披露关于HP570片临床试验申请获得美国FDA批准的公告2026-11-05 契約の締結 关于签署独家授权许可协议的公告CN¥45.90CN¥27.68May 6Nov 6
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥45.90May 12
6-Month LowCN¥27.68Oct 22
3-Month Change−2.1%vs Aug 6
6-Month Change−23.8%vs May 6

If you had invested CN¥10,000 6 months ago, it would be worth CN¥7,624 today (−23.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −12.3%, while this stock moved −23.8%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥33.59+10.3%
Oct 2026CN¥30.46−8.6%
Sep 2026CN¥33.34+0.8%
Aug 2026CN¥33.06+0.9%
Jul 2026CN¥32.76−6.9%
Jun 2026CN¥35.17−11.5%
May 2026CN¥39.74−9.7%
2026-10-09 新薬・製品の承認 自愿披露关于HP515片IIa期临床试验数据被美国肝病研究协会接受为年…2026-10-31 第3四半期報告 2026年第三季度报告2026-11-04 新薬・製品の承認 自愿披露关于HP570片临床试验申请获得美国FDA批准的公告2026-11-05 契約の締結 关于签署独家授权许可协议的公告CN¥57.00CN¥27.68Nov 6Nov 6
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥57.00Dec 11
52-Week LowCN¥27.68Oct 22
Year to Date−31.7%vs Dec 31
From 52-Week High−41.1%Dec 11

If you had invested CN¥10,000 1 year ago, it would be worth CN¥7,039 today (−29.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.9%, while this stock moved −29.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥33.59+10.3%
Oct 2026CN¥30.46−8.6%
Sep 2026CN¥33.34+0.8%
Aug 2026CN¥33.06+0.9%
Jul 2026CN¥32.76−6.9%
Jun 2026CN¥35.17−11.5%
May 2026CN¥39.74−9.7%
Apr 2026CN¥44.00−0.0%
Mar 2026CN¥44.02−0.4%
Feb 2026CN¥44.19−3.9%
Jan 2026CN¥46.00−6.4%
Dec 2025CN¥49.17+2.8%
Nov 2025CN¥47.84−8.4%
CN¥66.03CN¥23.17Nov 6, 2023Nov 6, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥66.03Aug 11, 2025
3-Year LowCN¥23.17Jul 1, 2024
Annualized Return−9.6%
Max Drawdown−57.1%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥7,387 today (−26.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +20.1%, while this stock moved −26.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥33.59−31.7%
2025CN¥49.17―
CN¥74.97CN¥23.17Apr 11, 2022Nov 6, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥74.97Apr 24, 2023
5-Year LowCN¥23.17Jul 1, 2024
Annualized Return−2.6%
Max Drawdown−69.1%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥8,856 today (−11.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +13.6%, while this stock moved −11.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥33.59−31.7%
2025CN¥49.17―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2022). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.4 Disclosure 2026/11/05 09:00
契約の締結
关于签署独家授权许可协议的公告

📄 Open the filing

Delete
No.3 Disclosure 2026/11/04 09:00
新薬・製品の承認
自愿披露关于HP570片临床试验申请获得美国FDA批准的公告

📄 Open the filing

Delete
No.2 Disclosure 2026/10/31 09:00
第3四半期報告
2026年第三季度报告

📄 Open the filing

Delete
No.1 Disclosure 2026/10/09 09:00
新薬・製品の承認
自愿披露关于HP515片IIa期临床试验数据被美国肝病研究协会接受为年会最新突破摘要的公告

📄 Open the filing

Delete

Write on the Hinova Pharmaceuticals Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English